52. Genetic Banks, Databases and Biodiversity

Date Source Title Summary Other Categories
07.2001 Nature Genetics Protecting individuals and promoting science Two leading administrators have recently commented on the use and availability of information from medical research and practice.  Both agree that clear legislation is needed to tell doctors just what the law allows in medical database disclosure. 4. Ethical and Social Concerns Arising out of Biotechnology, 48. Privacy
07.02.2001 New York Times Gene Data to Be Kept Private so Company Can Make Drugs A pioneering database of human genes is now available for licensing again. But Human Genome Sciences, which controls the database, no longer plans to offer broad access to the data.
06.08.2001 Science Begging for Bioinformatics Two bioinformatics companies are hoping the Canadian government will join their bid to create a massive new public database on protein interactions. 54. Proteomics
05.06.2001 New York Times Patchwork Genes: A Survey of Global Genetic Diversity Biotechnology companies see a business opportunity in human diversity.  They are interested in populations around the world that have a higher-than-average concentration of rare genetic diseases.  Some companies have gone so far as to purchase the rights to these populations’ genes. 16. Economics and Biotechnology
04.04.2001 New York Times Oracle to Form Biotech Joint Venture Computer software giant Oracle Corp. announced it is forming an alliance with two biotechnology companies to map out human proteins and how they interact. 16. Economics and Biotechnology
03.15.2001 Washtech.com Celera Genomics Signs Database Pact With Arena Celera Genomics Group , a unit of Applera Corp., said on Thursday that Arena Pharmaceuticals Inc. has signed a multi-year subscription agreement to use Celera's databases for genomic research.
03.13.2001 New York Times Alliance to Develop Diabetes Drugs Abbott Laboratories and Millennium Pharmaceuticals said yesterday that they would pool their efforts to develop drugs and diagnostic tests for diabetes and obesity. The agreement, in which Abbott agreed to buy $250 million of Millennium's stock, is the latest alliance between a big pharmaceutical company and a genomics company. 55. Pharmaceutical and Genomics Efforts/Developments 
01.04.2001 Nature Global biodiversity plan needs to convince local policy-makers [Correspondence] Discussion on the Conservation International (CI) blueprint to save biodiversity (covering protection of biodiversity hotspots and tropical wilderness areas) as it relates to Indonesian territory and policy, and how its analysis has been monopolized by North American concepts.
12.2000 Nature Genetics Genetic homogeneity of Icelanders Somewhat technical defence of the Icelandic gene pool as a suitable source for gene-mapping studies. The article is a reply to persons who challenged the notion that Icelanders are a relatively homogeneous population, and implied that this was a fiction promoted by a biotechnology company based in Iceland. The authors here systematically defend the homogeneity of the Icelandic gene pool.
12.2000 Nature Biotech First Genetic Trust banks on genes First Genetic Trust has put itself forward as "a third party intermediary among researchers, healthcare providers, and patients." by providing the operational infrastructure that enables the use of genetic information by industry in a secure, private, and reliable way. It will hold personal information accounts for those people who consent to be involved in genomic studies. As with a bank account, that information is owned by the individual, but it resides at First Genetic Trust.
01.11.2001 Nature Estonians give green light to gene bank The Estonian parliament approved the Human Gene Research Act. This legislation will regulate the creation, maintenance and use of a national gene bank in Estonia.
11.28.2000 Pacific Islands Report Tonga Agrees to DNA Commercialization An example of country-commercial cooperation in biotechnology development. Here, studies are conducted using genetic data from the Tonga population. Commercialization benefits are explained. 16. Economics and Biotechnology
11.27.2000 Wired News Tonga Sells Its Old, New Genes An Australian biotechnology company, Autogen Limited has signed an agreement with Tonga's Ministry of Health to build its own private genetic database from the 108,000 people of the Kingdom of Tonga. 16. Economics and Biotechnology